Charles River Laboratories (CRL) Tops Q1 EPS by 12c, provides guidance
Tweet
Share
E-mail
Get Alerts CRL Hot Sheet
Price: $185.00 +1.46%
Revenue Growth %: -5.1%
Financial Fact:
Operating income: 58.8M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: -5.1%
Financial Fact:
Operating income: 58.8M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q1 EPS of $2.06, $0.12 better than the analyst estimate of $1.94. Revenue for the quarter came in at $995.8 million versus the consensus estimate of $978.34 million.
GUIDANCE:
Charles River Laboratories sees FY 2026 EPS of $10.80-$11.30, versus the consensus of $11.07.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Upgrades China Resources Microelectronics Ltd (688396:CH) to Neutral
- Morgan Stanley Downgrades Sands China Ltd. (1928:HK) (SCHYY) to Equalweight
- Berenberg Downgrades Umicore SA (UMI:BB) (UMICY) to Hold
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
